• AEMECON 2024 will be an in-person conference; authors must attend and present at the conference in person.

• Papers may have multiple authors; at least one author must register for and attend the conference.

• The submitting author should input all author details and upload their abstract using the abstract submission form.

• Before uploading the abstract, the candidate must register for the conference.

• Authors should indicate the type of submission (paper, poster) on the form and whether they are willing to accept an alternate format.

• The student's original work (study) will preferably be accepted as a paper.

• Case reports and case series should be submitted under the poster category.

• The Scientific Committee will carefully review all submitted abstracts to determine the most suitable presentation format, whether it be an oral paper or a poster presentation. The decision will be based on the quality and relevance of the abstract to the conference theme.

• The committee will make every effort to ensure that the selected presentation format aligns with the significance and impact of your research.

​Submission Types

 

Original Studies

These face-to-face live sessions are approximately 6 minutes, followed by a question period.

Case Reports

Posters will be displayed in the conference hall and presented during tea and lunch breaks.
 

Original Studies

• Be written in English.

• Use a word count of 250 words or less (excluding title, keywords, and references)

• Include a title of 12 words maximum.

• Include three keywords.

​

Use the following headings for original studies

• Title (12 words maximum)

• Name of the presenting author and his coauthors with their affiliations

• Introduction/Background

• Methods

• Results

• Conclusion

• Disclosures

​

Case Reports

• Be written in English

 

Use the following headings for case reports

 

• TITLE OF CASE - Use up to 15 words

• INTRODUCTION - Give the context of the case

• CASE SUMMARY (PRESENTATION, RELEVANT INVESTIGATIONS, IMAGING AND MANAGEMENT) - Give a comprehensive account of the presenting features. Do not use abbreviations for diseases or investigations; use internationally accepted units. Use only scientific names of drugs. All investigations that create a background (baseline) picture are relevant. Remove all details that identify the patient. Include pharmacological and non-pharmacological treatment. Include follow-up data

• LEARNING POINTS/TAKE HOME MESSAGE - In bullet points (1 to 2 points)

 

Deadline

• The last date for abstract submission is February 21st, 2024.

• The deadline to inform delegates about their selection of abstract is March 2nd, 2024.

• The last date to confirm their participation in the oral/poster presentation is March 7th, 2024​

​​

Abstract Awards

• Oral presentation

First and Second place would be awarded with a merit certificate

• Poster presentation

First and Second place would be awarded with a merit certificate

​